|
Published by: Frost & Sullivan
Published: Sep. 1, 2001
Table of Contents
1. Competitive Profiles of Key Industry Participants
A. Executive Summary
B. Research Methodology and Awards
1. Market Engineering Research Methodology
2. Market Engineering Leadership Award
3. Competitive Strategy Award
C. Implications of Key Competitive Factors
1. Market Drivers
2. Market Restraints
3. Market Challenges
4. Market Engineering Strategic Recommendations
D. Amersham Pharmacia Biotech
1. Corporate Overview
2. Core Proteomics Technologies and Product Pipeline
3. Financial Analysis and Revenue Forecasts
4. Key Strategic Developments
E. Applied Biosystems Group
1. Corporate Overview
2. Core Proteomics Technologies and Product Pipeline
3. Financial Analysis and Revenue Forecasts
4. Key Strategic Developments
F. Bio-Rad Laboratories, Inc.
1. Corporate Overview
2. Core Proteomics Technologies and Product Pipeline
3. Financial Analysis and Revenue Forecasts
4. Key Strategic Developments
G. Bruker Daltonics, Inc.
1. Corporate Overview
2. Core Proteomics Technologies and Product Pipeline
3. Financial Analysis and Revenue Forecasts
4. Key Strategic Developments
H. Ciphergen Biosystems, Inc.
1. Corporate Overview
2. Core Proteomics Technologies and Product Pipeline
3. Financial Analysis and Revenue Forecasts
4. Key Strategic Developments
I. Genomic Solutions, Inc.
1. Corporate Overview
2. Core Proteomics Technologies and Product Pipeline
3. Financial Analysis and Revenue Forecasts
4. Key Strategic Developments
J. Large Scale Biology Corporation
1. Corporate Overview
2. Core Proteomics Technologies and Product Pipeline
3. Financial Analysis and Revenue Forecasts
4. Key Strategic Developments
K. MDS Proteomics, Inc.
1. Corporate Overview
2. Core Proteomics Technologies and Product Pipeline
3. Financial Analysis and Revenue Forecasts
4. Key Strategic Developments
L. Thermo Finnigan
1. Corporate Overview
2. Core Proteomics Technologies and Product Pipeline
3. Financial Analysis and Revenue Forecasts
4. Key Strategic Developments
M. Waters Corporation
1. Corporate Overview
2. Core Proteomics Technologies and Product Pipeline
3. Financial Analysis and Revenue Forecasts
4. Key Strategic Developments
2. 2-Dimensional Gel Electrophoresis—The Heart of the Proteome Technology
3. Protein Chips
4. Mass Spectrometry
5. Liquid Chromatography
6. Integrated Systems
7. Structural Proteomics
8. Functional Proteomics
9. Analytical Laboratory Services Partial List of Figures
Chapter 1
Market Drivers in Order of Impact (World), 2001-2006
Chapter 2
Market Restraints in Order of Impact (World), 2001-2006
Chapter 3
Impact of Top Five Industry Challenges (World), 2001-2006
Chapter 4
Amersham Pharmacia Biotech Limited: 2001 Company Snapshot
Amersham Pharmacia Biotech: Core Proteomics Technologies
Amersham Pharmacia Biotech:Financial Analysis
Amersham Pharmacia Biotech: Research and Development Expenditures
Amersham Pharmacia Biotech: Strategic Developments
Applied Biosystems Group: 2001 Company Snapshot
Applied Biosystems Group: Core Proteomics Technologies
Applied Biosystems Group: Financial Analysis
Applied Biosystems Group: Research and Development Expenditures
Applied Biosystems Group: Major Proteomics Related Strategic Developments
Bio-Rad Laboratories, Incorporated: 2001 Company Snapshot
Bio-Rad Laboratories, Incorporated: Core Technologies
Bio-Rad Laboratories, Incorporated: Financial Analysis
Bio-Rad Laboratories, Incorporated: Research and Development Expenditures
Bio-Rad Laboratories, Incorporated: Key Strategic Developments
Bruker Daltonics, Incorporated: 2001 Company Snapshot
Bruker Daltonics, Incorporated: Core Proteomics Technologies
Bruker Daltonics, Incorporated: Financial Analysis
Bruker Daltonics, Incorporated: Research and Development Expenditures
Bruker Daltonics, Incorporated: Key Strategic Developments
Ciphergen Biosystems, Incorporated: 2001 Company Snapshot
Ciphergen Biosystems, Incorporated: Core Proteomics Technologies
Ciphergen Biosystems, Incorporated: Financial Analysis
Ciphergen Biosystems, Incorporated: Research and Development Expenditures
Ciphergen Biosystems, Incorporated: Key Strategic Developments
Genomic Solutions, Incorporated: 2001 Company Snapshot
Genomic Solutions, Incorporated: Core Technologies
Genomic Solutions, Incorporated: Financial Analysis
Genomic Solutions, Incorporated: Research and Development Expenditures
Genomic Solutions, Incorporated: Key Strategic Developments
Large Scale Biology Corporation: 2001 Company Snapshot
Large Scale Biology Corporation: Core Technologies
Large Scale Biology Corporation: Financial Analysis
Large Scale Biology Corporation: Research and Development Expenditures
Large Scale Biology Corporation: Key Strategic Developments
MDS Proteomics, Incorporated: 2001 Company Snapshot
MDS Proteomics, Incorporated: Core Technologies
MDS Proteomics, Incorporated: Financial Analysis
MDS Proteomics, Incorporated: Research and Development Expenditures
MDS Proteomics, Incorporated: Key Strategic Developments
Thermo Electron Corporation: 2001 Company Snapshot
Thermo Electron Corporation: Core Proteomics Technologies
Thermo Electron Corporation: Financial Analysis
Thermo Electron Corporation: Research and Development Expenditures
Thermo Electron Corporation: Key Strategic Developments
Waters Corporation: 2001 Company Snapshot
Waters Corporation: Core Proteomics Technologies
Waters Corporation: Financial Analysis
Waters Corporation: Research and Development Expenditures
Waters Corporation: Key Strategic Developments
AbstractDrive for Efficient Drug Discovery Spurs Proteomics Markets
As pharmaceutical firms strive to optimize drug development, proteomics, the
analysis of proteins expressed in human cells, will play an increasingly
important role in their efforts. By charting the distribution of proteins,
identifying and characterizing proteins of interest, and elucidating the
function of proteins in biochemical pathways, proteomics will boost the
number of potential drug targets around which lead compounds can be
screened and designed. Applying proteomic analysis to toxicology trials will
also allow drug companies to evaluate compounds faster, thereby minimizing
research and development expenditures.
This Frost & Sullivan research profiles leading participants in proteomic
markets. It provides a corporate overview for each firm, evaluates core
proteomics technologies and product offerings, and provides expert revenue
forecasts. With such a privileged view of the competitive field, users of this
study will gain important insights into the proteomics marketplace.
Genomic Information Gap Refocuses Research on Proteins
"Sequencing of the human genome revealed that there are far fewer genes
than scientists originally believed," says the analyst responsible for this study.
Furthermore, genomic data has provided little information on
post-translational modifications, the role of proteins in biochemical pathways,
or disease states. "Consequently, there has been a significant shift from
research on genomes to the large-scale high-throughput analysis of proteomes,"
states the author.
To generate the necessary throughput and achieve the required reproducibility,
market participants are moving toward integrated and automated proteomics
solutions. By tracking technology trends and assessing their impact on market
success, this study will enable your firm to better anticipate the future
direction of the industry.
Tool Providers Lead Revenue Gains
Proteomics companies can be divided into tool providers and drug discovery
firms. Presently, tool providers generate the majority of revenues in the
marketplace. "Firms engaged in downstream activities will generate more
revenues in the mid to long-term through the identification of biomarkers as
well as the development of antibody and small molecule therapeutics," says
the analyst.
Ultimately, drug discovery efforts will help companies build significant IP
portfolios and establish long-term value propositions. This research examines
the strategies of major competitors and highlights winning strategies.
Combined with other essential research from Frost & Sullivan's Proteomics
Market Service, this study gives its users a comprehensive guide to a
burgeoning field.
Get Full Details About This Report >>
|
